Mistras Group, Inc. MG R2K
Company Overview
Mistras Group, Inc. provides technology-enabled industrial asset integrity and laboratory testing solutions in the United States, Europe, the Middle East, Africa, Asia, and South America. The company offers non-destructive testing (NDT) services; pipeline inspections; Plant Condition Management Software; maintenance planning; and specialized engineering solutions. It also provides maintenance and light mechanical services, such as corrosion removal, mitigation and prevention, insulation installation and removal, electrical services, heat tracing, industrial cleaning, pipefitting, and welding; engineering consulting services, including plant operations and management support, turnaround/shutdown planning, profit improvement, facilities planning studies, engineering design, process safety reviews, energy optimization evaluations, benchmarking/key performance indicator development, and technical training. In addition, the company offers scaffolding and rope access forb at-height and confined assets; certified divers for subsea inspection and maintenance; unmanned aerial, land-based, and subsea systems for inspection applications; portable, handheld, wireless and turnkey NDT equipment; acoustic emission products and sensors, instruments, and turnkey systems for monitoring and testing materials, pressure components, processes, and structures; and ultrasonic testing equipment. Further, it provides asset protection solutions to detect, mitigate, and prevent degradation mechanisms, such as corrosion, cracking, leaks, and manufacturing defects; inspection, maintenance, and monitoring and data services; and quality assurance and quality control solutions for new and existing metal and alloy components, materials, and composites. It serves renewable energy, alternative power generation, natural gas transportation, data centers, pipeline integrity, and additive manufacturing industries. The company was founded in 1978 and is headquartered in Princeton Junction, New Jersey.
Why Investors Should Care
Trades at a P/E of 23.5, below the sector median of 30.2.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $724.02M (-0.8% YoY); net profit $16.84M.
- Trailing 12 Months Year-on-year growth — revenue +4.6%, earnings -11.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 6.3%, profit CAGR 3.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 6.31% |
| 1 Year: | 4.60% |
Compounded Profit Growth
| 5 Years: | 3.04% |
| 1 Year: | -11.19% |
Stock Price Performance
| 1 Year: | +102.96% |
| 6 Months: | +19.56% |
| 3 Months: | -3.58% |
| 1 Month: | -11.76% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)37.45 · Neutral
P/E of 23.49 is below the sector median of 30.17 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MG Mistras Group, Inc. R2K | 16.44 | 23.49 | $523.07M | 0.00% | 8.93% | 10.38% | 6.31% | 3.04% |
| 2 | CAT Caterpillar Inc. SPX | 933.34 | 46.39 | $429.89B | 0.72% | 17.98% | 51.33% | 2.29% | 5.24% |
| 3 | GE GE Aerospace SPX | 353.73 | 43.94 | $369.06B | 0.56% | 11.89% | 45.43% | 16.32% | 195.89% |
| 4 | GEV GE Vernova Inc. SPXAI | 1,066.01 | 31.13 | $286.46B | 0.21% | 6.30% | 75.71% | 8.68% | - |
| 5 | RTX RTX Corporation SPX | 193.39 | 36.35 | $260.44B | 1.51% | 8.28% | 11.57% | 2.61% | 2.62% |
| 6 | UNP Union Pacific Corporation SPX | 288.30 | 23.71 | $171.17B | 2.02% | 15.22% | 40.69% | 2.30% | 7.77% |
| 7 | BA The Boeing Company SPX | 217.11 | 86.15 | $171.15B | 0.00% | -9.01% | - | 1.67% | -3.28% |
| 8 | ETN Eaton Corporation plc SPXAI | 415.52 | 40.66 | $161.35B | 1.12% | 11.53% | 20.84% | 4.73% | 10.38% |
| 9 | DE Deere & Company SPX | 584.40 | 33.07 | $157.85B | 1.12% | - | 18.35% | 3.43% | 5.10% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2016 | Aug 2016 | Sep 2016 | Nov 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 163.32M | 170.44M | 179.57M | 187.64M | 187.63M | 191.79M | 182.17M | 180.76M | 176.79M | 200.62M | 192.19M | 178.99M | 159.47M | 124.44M | 147.89M | 160.78M | 153.74M | 177.68M | 174.56M | 171.16M | 161.66M | 179.03M | 178.46M | 168.22M | 168.02M | 176.03M | 179.35M | 182.07M | 184.44M | 189.77M | 182.69M | 161.62M | 185.41M | 195.55M | 169.03M |
| Gross Profit | 51.53M | 50.06M | 50.65M | 52.08M | 47.98M | 43.15M | 46.34M | 47.90M | 50.32M | 48.14M | 55.08M | 52.33M | 52.31M | 48.87M | 60.07M | 57.77M | 50.58M | 40.64M | 41.16M | 47.38M | 49.34M | 40.00M | 55.34M | 52.22M | 49.59M | 39.89M | 53.56M | 53.78M | 50.94M | 46.08M | 49.72M | 54.38M | 53.63M | 46.15M | 51.34M | 48.91M | 40.89M | 53.95M | 58.19M | 44.73M |
| Operating Income | 4.84M | 11.15M | 12.12M | 12.51M | 2.94M | 3.25M | 5.00M | -10.38M | 6.28M | 6.40M | 10.30M | 3.02M | 2.50M | -4.40M | 15.42M | 10.78M | 2.33M | -111.23M | -383.00K | 5.74M | 4.65M | -4.75M | 11.37M | 9.24M | 2.31M | -4.70M | 9.58M | 9.11M | 5.80M | -1.83M | 3.89M | -4.68M | 706.00K | 5.55M | 11.96M | 11.86M | -1.01M | 8.43M | 20.38M | 4.68M |
| Net Income | 2.76M | 6.60M | 7.24M | 7.27M | 963.00K | 1.69M | 2.22M | -6.97M | 884.00K | 2.91M | 6.00M | -1.01M | -1.06M | -5.29M | 7.43M | 3.09M | 829.00K | -98.51M | -2.66M | 1.52M | 181.00K | -5.36M | 5.94M | 3.38M | -94.00K | -5.36M | 4.64M | 4.37M | 2.84M | -4.99M | 337.00K | -10.30M | -2.51M | 995.00K | 6.37M | 6.40M | -3.19M | 3.02M | 13.11M | 2.39M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.18 | - | - | - | -0.17 | - | - | - | 0.03 | 0.20 | 0.20 | -0.10 | 0.10 | 0.41 | 0.07 |
| R&D Expense | 623.00K | 632.00K | 643.00K | 580.00K | - | 643.00K | 552.00K | 555.00K | - | 756.00K | 913.00K | 745.00K | - | 857.00K | 754.00K | 650.00K | - | 824.00K | 708.00K | 638.00K | - | 727.00K | 620.00K | 595.00K | - | 551.00K | 522.00K | 450.00K | - | 480.00K | 511.00K | 438.00K | - | 343.00K | 231.00K | 241.00K | 299.00K | 269.00K | 210.00K | 221.00K |
Profit & Loss (Annual)
Figures in USD.
| Metric | May 2010 | May 2011 | May 2012 | May 2013 | May 2014 | May 2015 | May 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 272.13M | 338.59M | 436.88M | 529.28M | 623.45M | 711.25M | 719.18M | 684.76M | 700.97M | 742.35M | 748.59M | 592.57M | 677.13M | 687.37M | 705.47M | 729.64M | 724.02M |
| Gross Profit | 83.14M | 103.40M | 129.69M | 148.37M | 172.94M | 184.73M | 203.01M | 194.13M | 187.71M | 207.87M | 217.30M | 178.53M | 197.15M | 198.17M | 184.30M | 192.17M | 204.51M |
| Operating Income | 20.90M | 29.61M | 36.10M | 27.55M | 38.30M | 30.35M | 43.18M | 25.55M | 4.16M | 22.22M | 24.14M | -101.22M | 18.17M | 19.80M | -1.90M | 39.83M | 40.57M |
| Net Income | 10.43M | 16.43M | 21.35M | 11.65M | 22.52M | 16.08M | 24.65M | 14.41M | -2.17M | 6.84M | 6.06M | -99.46M | 3.86M | 6.50M | -17.45M | 18.96M | 16.84M |
| Diluted EPS | - | - | - | - | - | 0.54 | 0.82 | - | -0.08 | 0.23 | 0.21 | -3.41 | 0.13 | 0.21 | -0.58 | 0.60 | 0.53 |
| R&D Expense | 2.40M | 2.15M | 2.06M | 2.45M | 3.00M | 2.52M | 2.52M | 2.67M | 2.27M | 3.31M | 3.04M | 2.89M | 2.52M | 1.99M | 1.72M | 1.12M | 1.03M |
Balance Sheet (Annual)
Figures in USD.
| Metric | May 2009 | May 2010 | May 2011 | May 2012 | May 2013 | May 2014 | May 2015 | May 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 248.64M | 329.82M | 378.00M | 443.97M | 471.73M | 482.68M | 469.43M | 554.44M | 694.04M | 719.88M | 583.31M | 562.20M | 534.90M | 534.78M | 523.04M | 578.78M |
| Total Equity | -47.67M | 130.55M | 167.16M | 193.01M | 210.05M | 242.10M | 244.82M | 276.16M | 270.58M | 270.62M | 270.90M | 285.82M | 197.02M | 200.68M | 198.45M | 190.19M | 198.57M | 235.10M |
| Cash & Equivalents | 5.67M | 16.04M | 10.88M | 8.41M | 7.80M | 10.02M | 10.55M | 21.19M | 19.15M | 27.54M | 25.54M | 15.02M | 25.76M | 24.11M | 20.49M | 17.65M | 18.32M | 28.01M |
| Long Term Debt | - | - | 14.62M | 34.26M | 52.85M | 68.59M | 95.56M | 72.46M | 85.92M | 164.52M | 283.79M | 248.12M | 209.54M | 182.40M | 183.83M | 181.50M | 158.06M | 165.14M |
| Total Liabilities | - | - | 81.15M | 136.57M | 167.72M | 201.58M | 226.72M | 206.39M | 198.68M | 283.65M | 422.96M | 433.86M | 386.09M | 361.28M | 336.15M | 344.27M | 324.14M | 343.14M |
| Current Liabilities | - | - | 50.59M | 64.32M | 72.22M | 86.79M | 93.52M | 96.88M | 77.71M | 90.22M | 100.47M | 109.24M | 109.85M | 121.42M | 103.73M | 116.52M | 114.92M | 124.31M |
Cash Flows (Annual)
Figures in USD.
| Metric | May 2010 | May 2011 | May 2012 | May 2013 | May 2014 | May 2015 | May 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - | 68.12M | 55.80M | 41.66M | 59.11M | 67.80M | 42.26M | 26.41M | 26.75M | 50.13M | 32.98M |
| Investing Cash Flow | - | - | - | - | - | -49.65M | -16.75M | -102.80M | -155.45M | -25.28M | -14.97M | -18.55M | -12.24M | -22.13M | -21.37M | -25.12M |
| Financing Cash Flow | - | - | - | - | - | - | -40.38M | 53.05M | 113.97M | -44.14M | -44.17M | -23.25M | -16.32M | -7.71M | -27.40M | -595.00K |
| Capital Expenditure | -1.95M | -10.07M | -9.59M | -12.53M | -16.87M | -15.10M | -14.86M | -19.31M | -20.58M | -22.05M | -15.40M | -18.16M | -12.59M | -20.85M | -17.90M | -24.67M |
| Free Cash Flow | - | - | - | - | - | - | 53.26M | 36.48M | 21.08M | 37.06M | 52.41M | 24.10M | 13.81M | 5.89M | 32.23M | 8.31M |
| Share Buybacks | - | - | - | - | - | 0 | 0 | 15.92M | 0 | 0 | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | May 2010 | May 2011 | May 2012 | May 2013 | May 2014 | May 2015 | May 2016 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 30.6% | 30.5% | 29.7% | 28.0% | 27.7% | 26.0% | 28.2% | 28.4% | 26.8% | 28.0% | 29.0% | 30.1% | 29.1% | 28.8% | 26.1% | 26.3% | 28.2% |
| Operating Margin % | 7.7% | 8.7% | 8.3% | 5.2% | 6.1% | 4.3% | 6.0% | 3.7% | 0.6% | 3.0% | 3.2% | -17.1% | 2.7% | 2.9% | -0.3% | 5.5% | 5.6% |
| Net Margin % | 3.8% | 4.9% | 4.9% | 2.2% | 3.6% | 2.3% | 3.4% | 2.1% | -0.3% | 0.9% | 0.8% | -16.8% | 0.6% | 0.9% | -2.5% | 2.6% | 2.3% |
| ROE % | 8.0% | 9.8% | 11.1% | 5.5% | 9.3% | 6.6% | 8.9% | 5.3% | -0.8% | 2.5% | 2.1% | -50.5% | 1.9% | 3.3% | -9.2% | 9.5% | 7.2% |
| ROCE % | - | 15.0% | 13.6% | 9.0% | 10.7% | 8.0% | 11.2% | 6.5% | 0.9% | 3.7% | 4.0% | -21.4% | 4.1% | 4.6% | -0.5% | 9.8% | 8.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Mill Road Capital Management Llc | 5.88% | 1.87M | $31.76M |
| 2 | Dimensional Fund Advisors LP | 5.35% | 1.70M | $28.93M |
| 3 | Royce & Associates LP | 4.82% | 1.53M | $26.03M |
| 4 | Weber Capital Management LLC /ADV | 4.58% | 1.46M | $24.74M |
| 5 | Ies Holdings, Inc. | 3.52% | 1.12M | $19.03M |
| 6 | Vanguard Capital Management LLC | 2.92% | 930.18K | $15.79M |
| 7 | Blackrock Inc. | 2.70% | 859.45K | $14.59M |
| 8 | Federated Hermes, Inc. | 2.06% | 656.03K | $11.14M |
| 9 | Clearline Capital, LP | 1.74% | 554.09K | $9.41M |
| 10 | Invenomic Capital Management, LP | 1.42% | 452.61K | $7.69M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MG
CervoMed Reports Stable Right Basal Forebrain Volume Over 48 Weeks - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPWlFNRWVqc3pyNHpET1VlUlFWNFNXeWRJYklVSm9DZWVpekJ6TjlpOUZrN1F2Y1BmUjJ6enVsbmVJRVkwUjNCVnVOQ3JPR3Z6X2xnUkRJSldBX190eWpjTUtqMjIwRFdRZ09fTm9jRXV6YlQyeG9Xa0FKeTZyci16QTlnakNhZUxXUktOcE…
Price to sales forward of Mistras Group Inc – NYSE:MG - TradingView
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNcGZtWmswbEprdXdrXzVEUVJQWllHemtPSUNfYUctaUFaTkljcDhCOXRfdjd1LV9DQmFIb3NTNE82S0NFTk1mQ29PaXhuZnQwUzNUNHRvVEhDLXdqSXViRkFieTFfN0tCQWU2cXl4SzdqZVQ3cjM4ZmFoMWRaVFRPZk1UYUQzTzh3S3RqSj…
Mistras Group Inc (MG) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPY3pqMFctS0stbEx6US1xVWczYzFnOUtYT1daVF9SQU8yWGxDcmE2NlVGbWxLcmY1RHBvVVZCTG1LY0t0ZlpPaGFQc245Snpxbmw2UHJ1cmFzN3pTeE00Mjgxc1RYaDJfNGFUVm5ReWVjYWRCV21PelR4Y1dHaWRfQXk4V0N4ZkxHekF0Y3…
(MG) Volatility Zones as Tactical Triggers - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxPTG5KSlFwdUZWZDlxOFNONUJJLXNBNW4yTng5c0xNWmM0QjhjcDJXTFNNVnFNN0JVeXM2N3NRWDg3TkdfT203LUVCaXhTQVRZa3oyNDVmUjI1eF9NbVQzLUE5U2N4SHVZLU83VnZaVGhXMEVicHdWWThkQkZWcDU3OTFxQm94aDdpQVJxQX…
Leqembi Iqlik Gets FDA Approval for At-Home Treatment Start - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPR3ZaV3hxVjZhazhCcExxdlQ0WHR1dDAwUDMwdEo4VFNtOHE3emZzdWVJNTEtdFA3dndQb0RQWEN0ZEVLNktWakhyczRWbHl4N0VINEtwb19HNEc0U2kzQ1NzN2RMWFdWTTN2dVMtd3JUVHotb1FWNmNyZU9JX0hCZks5NFhDWHdJLWhfT2…
USMCA Risk Puts Magna International Stock And North American Trade Exposed Shares In Focus - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi6AFBVV95cUxNaU42c1lMRjQ5d0dqLVo0YUlvc2JqWDN3LTNZU1Z6bHJhWEt0Y2pSTHVtTF9jLXdrbUFwQkNOZXlGZlJSODVWZmtyX2RpQlB6Yk9wTlVicWstQ21HdHo3UnB4dEs4cXZIcnJSTDcyZXN4RkZma3V4QmdDcTFodm1WTHRQam1OdXdFMXRUdD…
MG — Frequently Asked Questions
What is the current share price of Mistras Group, Inc. (MG)?
As of 2026-07-14 21:23 PDT, Mistras Group, Inc. (MG) trades at $16.44 on NYSE. Its 52-week range is $7.83 to $19.28.
What is the market capitalisation of MG?
Mistras Group, Inc. (MG) has a market capitalisation of $523.07M on NYSE.
What is the P/E ratio of MG?
MG trades at a trailing price-to-earnings (P/E) ratio of 23.49. The industry average P/E is 30.17. Its price-to-book (P/B) ratio is 2.54.
What is the return on equity (ROE) of MG?
MG has a return on equity (ROE) of 10.38%. Its return on capital employed (ROCE) is 8.93%.
Is MG a good stock to buy?
This page provides a data-driven analysis of Mistras Group, Inc. (MG), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.